The Commercial Advantage Of Softgels

By Fergus Binnie, Formulation Development Team Leader at Douglas CDMO

Long-term success in developing new pharmaceuticals goes far beyond simply demonstrating clinical efficacy. To achieve a sustainable and meaningful impact on the market, it requires a comprehensive formulation strategy focused on several key factors. Optimizing bioavailability is essential to ensure that the active ingredients are effectively absorbed and utilized by the body. At the same time, enhancing patient compliance and overall experience is critical, as ease of use and comfort directly influence adherence to treatment regimens. Additionally, extending the product’s lifecycle value through innovative delivery methods can provide ongoing commercial benefits.

Among the various oral dosage forms, softgel capsules stand out as a highly versatile and high-performance option. Their unique structure allows for superior delivery characteristics, including improved solubility and stability of formulations. Softgels also offer consumer appeal due to their smooth texture and easy swallowing experience, which can lead to better patient acceptance. Moreover, they provide valuable opportunities for brand differentiation in a crowded pharmaceutical market.

Partnering with a specialized contract development and manufacturing organization (CDMO) to harness this advanced softgel technology represents a strategic investment. This collaboration grants access to expert formulation development, cutting-edge manufacturing processes, and quality assurance capabilities.